Orencia clickject 125 MG/mlml
Ended Awarded
- Contract number
- SPE2DB25FK36U
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $38,328
Award facts
- Contract value 100% obligated
- $38,328.21 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $38,328.21 to AmerisourceBergen Drug Corp for Orencia ClickJect 125 mg/mL on August 26, 2025, with an ultimate completion date of August 27, 2025. This is a firm fixed price, non-set-aside contract with performance in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. This prime indefinite delivery vehicle provides comprehensive global pharmaceutical support, enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to military healthcare systems and other federal customers worldwide.
Orencia (abatacept) is a biologic immunosuppressant medication used primarily for treating rheumatoid arthritis and other autoimmune conditions. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has demonstrated extensive capability in fulfilling federal medical procurement needs through the DLA's medical supply chain. The company's contract portfolio includes specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains. This delivery order reflects the ongoing operational need within the Defense Health Agency and military healthcare systems to maintain access to critical biologic therapies for eligible beneficiaries.
Quick answers
Who was awarded contract SPE2DB25FK36U?
SPE2DB25FK36U was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 26, 2025.
How much is contract SPE2DB25FK36U worth?
The government has obligated $38,328 on SPE2DB25FK36U.
Is contract SPE2DB25FK36U an order under another contract?
Yes. SPE2DB25FK36U is a delivery order under SPE2DB20D1110, an indefinite delivery contract.
Was contract SPE2DB25FK36U competed?
The extent of competition for SPE2DB25FK36U was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award